Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of beta-amyloid toxicity

Cell Biology and Toxicology
Alessandro CastorinaVelia D'Agata

Abstract

Amyloid beta peptide (Abeta), generated by proteolytic cleavage of the amyloid precursor protein (APP), plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). The key step in the generation of Abeta is cleavage of APP by beta-secretases (beta-site APP-cleaving enzyme 1 (BACE1) and BACE2). There has been suggestion of interaction between aluminum and several AD-associated pathways. However, the underlying mechanisms still remain unclear. Here, we report the effects of aluminum chloride (AlCl(3)) in Abeta-induced toxicity using differentiated neuronal SH-SY5Y cells. The metal significantly enhances Abeta-induced cell death at concentrations ranging from 50 to 300 microM after 24 and 48 h. After 72 and 96 h treatment, cell death is increased already at 10 microM. Early coexposure of cells to 10 microM AlCl(3) and 2 microM Abeta differentially affected beta-secretase mRNA levels as compared to single Abeta treatment after 1 and 3 h. BACE1 levels were slightly reduced after 1 h and significantly increased after 3 h exposure, whereas BACE2 levels were increased at both times considered. Both genes' mRNA levels were downregulated at longer times (6, 12, and 24 h). Although these results indicate that aluminum toxicity i...Continue Reading

References

Jan 1, 1991·Journal of Neuroscience Research·K C BreenB H Anderton
Jun 1, 1991·Lancet·D R Crapper McLachlanD F Andrews
May 7, 1990·Brain Research·F G KlierD Schubert
Nov 1, 1989·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·D R McLachlanT P Kruck
Mar 1, 1986·Environmental Health Perspectives·P O Ganrot
Nov 1, 1994·The Tohoku Journal of Experimental Medicine·Y Kuroda, M Kawahara
Nov 15, 1996·Journal of Neuroscience Research·D NeillJ A Edwardson
Jun 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M H TranT Nabeshima
Jul 12, 2002·Annals of Neurology·R M Damian HolsingerGeneviève Evin
Sep 12, 2002·Archives of Neurology·Hiroaki FukumotoMichael C Irizarry
Nov 5, 2002·Annual Review of Pharmacology and Toxicology·Dennis J Selkoe, Dale Schenk
Nov 20, 2002·Neuroreport·Luisa Benerini GattaDario Finazzi
Mar 14, 2003·Biochimica Et Biophysica Acta·Joungil ChoiRobert W Gracy
Aug 28, 2003·Brain Research. Molecular Brain Research·Paul PreeceNigel J Cairns
Sep 10, 2003·The International Journal of Neuroscience·Andrei C MiuAdrian I Olteanu
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Rena LiYong Shen
Mar 3, 2004·Journal of Neural Transmission·M H MohajeriR M Nitsch
May 6, 2004·Journal of Molecular Neuroscience : MN·Robert Vassar
Oct 7, 2004·Current Opinion in Neurobiology·Valérie Wilquet, Bart De Strooper
Apr 29, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiulian SunWeihong Song
Oct 19, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Md Riyaz BashaN H Zawia
Nov 11, 2005·Toxicology Letters·Bernd RossbachStephan Letzel
Nov 26, 2005·Journal of Alzheimer's Disease : JAD·Masahiro Kawahara
Nov 23, 2006·Journal of Alzheimer's Disease : JAD·Bettina Platt
Dec 22, 2007·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Daniel KrewskiVirginie Rondeau
Feb 6, 2008·The Biochemical Journal·Michael A CaterAshley I Bush

❮ Previous
Next ❯

Citations

Feb 5, 2013·International Journal of Nanomedicine·Manal Fouad IsmailNeveen Abdel-Hameed Salem
Jul 25, 2014·The International Journal of Biochemistry & Cell Biology·Salvatore GiuntaAlessandro Castorina
Jan 3, 2012·Environmental Toxicology and Pharmacology·Xiao-Bo LiHermann J Schluesener
Apr 18, 2015·Neural Regeneration Research·Rubina Marzagalli, Alessandro Castorina
Mar 23, 2011·International Journal of Alzheimer's Disease·Masahiro Kawahara, Midori Kato-Negishi
Apr 18, 2012·International Journal of Immunopathology and Pharmacology·Q L ZhangQ Niu
Aug 1, 2019·Archives of Toxicology·Karine P ReichertVera M M Morsch
Jun 20, 2017·Molecular Medicine Reports·Feng WangDe-Wu Han
Jan 5, 2021·Journal of Biochemical and Molecular Toxicology·Tauqeerunnisa Syeda, Jason R Cannon
May 25, 2021·Frontiers in Pharmacology·Grazia MaugeriSalvatore Giunta
Aug 21, 2021·ACS Chemical Neuroscience·Huan LiQiao Niu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.